Chemical Structure (Daptomycin 01)
Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-066
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 70594-066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (350 mg Vial Carton)
Principal Display Panel (500 mg Vial Carton)
This text appears to be a description of a medication for intravenous use. The medication is called "Daptomycin for Injection" and each vial contains 268.7 mg of Leucine, 1436 mg of Isoleucine, and 405 g of Lisoleucine. The pH of the medication is adjusted using Hyarochionc acid. The medication does not contain any preservatives. The text also provides information on how to reconstitute the medication using sterile water for injection or bacteriostatic water for injection. The medication is stored at a temperature between 20°C to 25°C and any unused portion should be discarded. There is a mention of "Prescribing Information" enclosed in the package for further instructions on dosage and administration. The text also includes the contact information of the manufacturer, Pharmaceuticals USA, LLC, located in Bufao Grove, L 60089, with the statement "Made in Inda".*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
